Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Transplantation

• Publication date

  2005-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000159029.48678.93PMID 15940052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00)

  2004cited by this paper
• Human Mesenchymal Stem Cells Form Purkinje Fibers in Fetal Sheep Heart

  2004cited by this paper
• Immunologic properties of human fetal mesenchymal stem cells.

  2004cited by this paper
• Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

  2003cited by this paper
• Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture

  2003cited by this paper
• HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

  2003cited by this paper
• Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

  2003cited by this paper
• Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma

  2003cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003cited by this paper
• Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma

  2003cited by this paper
• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  2003cited by this paper
• Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells

  2003cited by this paper
• Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

  2002cited by this paper
• Fetal Hematopoietic Stem Cell Transplantation: A Challenge for the Twenty-First Century

  2002cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

  2002cited by this paper
• Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

  2002cited by this paper
• Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

  2002cited by this paper
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002cited by this paper
• Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.

  2001cited by this paper
• Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

  2001cited by this paper
• Collagens and collagen-related diseases

  2001cited by this paper
• Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation.

  2000cited by this paper
• Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

  2000cited by this paper
• Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.

  2000cited by this paper
• Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero.

  1999cited by this paper
• In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers.

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

  1999cited by this paper
• Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice

  1999cited by this paper
• Osteoprogenitor Cells as Targets for Ex Vivo Gene Transfer

  1998cited by this paper
• Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

  1998cited by this paper
• Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations.

  1998cited by this paper
• Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.

  1998cited by this paper
• Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally.

  1997cited by this paper
• Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics

  1997cited by this paper
• Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

  1997cited by this paper
• Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies.

  1996cited by this paper
• Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.

  1995cited by this paper
• Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.

  1993cited by this paper
• Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.

  1992cited by this paper
• Osteogenesis imperfecta: translation of mutation to phenotype.

  1991cited by this paper
• Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II

  1985cited by this paper
• Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity.

  1979cited by this paper

• What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?

  2026cites this paper
• The fetal frontier: A review of current and emerging fetal therapies for genetic diseases.

  2026cites this paper
• Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review

  2025cites this paper
• Intrauterine Fetal Therapy: Past, Current, and Future

  2025cites this paper
• Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations

  2025cites this paper
• Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta

  2025cites this paper
• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells

  2025cites this paper
• The use of mesenchymal stem cells in the treatment of osteogenesis imperfecta: An integrative and qualitative review of literature

  2025cites this paper
• New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review

  2024cites this paper
• Fetal therapies - (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies).

  2024cites this paper
• Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.

  2024cites this paper
• Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial

  2024cites this paper
• Stem Cells in Bone Tissue Engineering: Progress, Promises and Challenges

  2024cites this paper
• Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review

  2023cites this paper
• Extracellular Vesicles and Cellular Ageing.

  2023cites this paper
• TITLE: New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs.

  2023cites this paper
• Mesenchymal stem cells in the treatment of osteogenesis imperfecta

  2023cites this paper
• Immunomodulation by mesenchymal stem cells during osteogenic differentiation: Clinical implications during bone regeneration.

  2023cites this paper
• Molecular Biomarkers in Perthes Disease: A Review

  2023cites this paper
• Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells

  2023cites this paper
• Therapeutic Potential of Human Fetal Mesenchymal Stem Cells in Musculoskeletal Disorders: A Narrative Review

  2022influential citation
• Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life

  2022cites this paper
• Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease.

  2022cites this paper
• Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders

  2022cites this paper
• Mesenchymal Stem Cell Therapeutic Potential in Regenerative Medicine and Its Future Direction

  2022cites this paper
• Recent developments in osteogenesis imperfecta [version 1; peer review: 3 approved]

  2022cites this paper
• In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death

  2022cites this paper
• Curative Cell and Gene Therapy for Osteogenesis Imperfecta

  2022cites this paper
• A systematic review and meta-analysis on the efficacy of stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta

  2021influential citation
• Cutting Edge Endogenous Promoting and Exogenous Driven Strategies for Bone Regeneration

  2021cites this paper
• Clinical trials in skeletal dysplasia: a paradigm for treating rare diseases.

  2021cites this paper
• Trophic effects of multiple administration of mesenchymal stem cells in children with osteogenesis imperfecta

  2021cites this paper
• Characterization of dental pulp stem cells isolated from a patient diagnosed with Crouzon syndrome

  2021cites this paper
• Mesencyhmal Stem Cell Therapy for Osteogenesis Imperfect.

  2021cites this paper
• Controlled induction of immune tolerance by mesenchymal stem cells transferred by maternal microchimerism.

  2021cites this paper
• Avaliação da combinação de injeções locais de células-tronco mesenquimais da medula óssea e do tecido adiposo na regeneração de defeitos ósseos de calvária de ratos

  2021cites this paper
• Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro‐osteogenic paracrine response: TERCELOI clinical trial

  2021cites this paper
• In Utero Stem Cell Transplantation, Enzyme Replacement, and Gene Therapy

  2021cites this paper
• The Future of Fetal Surgery.

  2021cites this paper
• Modern approaches on stem cells and scaffolding technology for osteogenic differentiation and regeneration

  2021cites this paper
• In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System

  2021cites this paper
• Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease

  2020cites this paper
• Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue

  2020cites this paper
• Osteogenesis imperfecta

  2020cites this paper
• Mesenchymal stromal cells in hematopoietic cell transplantation.

  2020cites this paper
• Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product

  2020cites this paper
• Mesenchymal stromal cells for osteonecrosis

  2020cites this paper
• Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta

  2020cites this paper
• Evaluation of Lactobacillus rhamnosus Antioxidant Effects on Survival of Human Mesenchymal Stem Cells

  2020cites this paper
• Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test

  2020cites this paper
• New perspectives on the treatment of skeletal dysplasia

  2020cites this paper
• Tissue Engineering and Stem Cell Research

  2020cites this paper
• A comparative study on immunophenotypic characterization and osteogenic differentiation of human Mesenchymal stromal cells derived from periodontal ligament and gingiva.

  2020cites this paper
• Application of Tissue Engineering and Regenerative Medicine in Maternal-Fetal Medicine.

  2020cites this paper
• Mesenchymal stem cells: amazing remedies for bone and cartilage defects

  2020cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Osteogenesis imperfecta: an update on clinical features and therapies.

  2020cites this paper
• Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease

  2019cites this paper
• Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A

  2019cites this paper
• Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta

  2019cites this paper
• scafSLICR: A MATLAB-based slicing algorithm to enable 3D-printing of tissue engineering scaffolds with heterogeneous porous microarchitecture

  2019cites this paper
• Fetal stem cell transplantation and gene therapy.

  2019cites this paper
• Immunomodulatory Effects of MSCs in Bone Healing

  2019cites this paper
• Cytoprotective Preconditioning of Osteoblast-Like Cells with N-Acetyl-L-Cysteine for Bone Regeneration in Cell Therapy

  2019cites this paper
• Stem Cell Transplantation: Clinical Potential in Treating Fetal Genetic Disease

  2019cites this paper
• Mesenchymal Stem Cells Treatment for Erectile Dysfunction in Diabetic Rats.

  2019cites this paper
• Use of Mesenchymal Stem/Stromal Cells for Pediatric Orthopedic Applications

  2019cites this paper
• Stem Cell Instruction via Appropriate Geometry and Local Curvature of Microstructured Polymeric Substrates

  2019cites this paper
• Ultrasound-guided in Utero Transplantation of Placental Stem Cells into the Liver of Crigler-Najjar Syndrome Model Rat.

  2019cites this paper
• Prenatal Genetic Testing Options.

  2019cites this paper
• Isolation and Characterization of an Adult Stem Cell Population from Human Epidural Fat

  2019cites this paper
• Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord

  2019cites this paper
• Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases

  2019cites this paper
• Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration

  2019cites this paper
• The evolving therapeutic landscape of genetic skeletal disorders

  2019cites this paper
• Suitability and limitations of mesenchymal stem cells to elucidate human bone illness

  2019cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Regenerative Medicine Applications of Mesenchymal Stem Cells.

  2018cites this paper
• Heritable Skeletal Disorders Arising from Defects in Processing and Transport of Type I Procollagen from the ER: Perspectives on Possible Therapeutic Approaches.

  2018cites this paper
• Osteogenesis imperfecta and therapeutics.

  2018cites this paper
• The Molecular Basis of Genetic Collagen Disorders and Its Clinical Relevance.

  2018cites this paper
• In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A

  2018cites this paper
• Cell Biology and Translational Medicine, Volume 2

  2018cites this paper
• Human coelomic fluid investigation: A MS-based analytical approach to prenatal screening

  2018cites this paper
• Rare genetic diseases: update on diagnosis, treatment and online resources.

  2018cites this paper
• Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy

  2018cites this paper
• Review ArticleMesenchymal Stem Cells and Orthopaedics (A Current Concept)

  2018cites this paper
• 9 Cell Therapy and Tissular Engineering to Regenerate Articular Cartilage

  2018cites this paper
• Sacralizaciones artísticas en los autos sacramentales de Lope. El caso de La puente del mundo

  2018cites this paper
• Perinatal regenerative medicine : development of autologous constructs for soft tissue defects

  2018cites this paper
• The Effect of Scaffold Modulus on the Morphology and Remodeling of Fetal Mesenchymal Stem Cells

  2018cites this paper
• Whole Exome Sequencing: Applications in Prenatal Genetics.

  2018cites this paper
• Bone repair potential of human amniotic fluid stem cells

  2018cites this paper
• Epiphyseal growth plate architecture is unaffected by early postnatal activation of the expression of R992C collagen II mutant.

  2018cites this paper
• Concise Review: Musculoskeletal Stem Cells to Treat Age‐Related Osteoporosis

  2017cites this paper
• MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells

  2017cites this paper
• Osteogenesis Imperfecta Type II in a 2-days-old Female Child from Tanzania: A Case Report and Review of Literature

  2017cites this paper
• Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?

  2017cites this paper
• Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders

  2017cites this paper
• Cell Transplantation – A Possible Alternative to Orthotopic Liver Transplant (OLT)

  2017cites this paper